Hepatic microsomal protein and cytochrome P-450 in BALB/c mice infected with Leishmania

Area of Science:

• Immunology
• Hepatology
• Parasitology

Background:

• Leishmania major is a parasite that infects macrophages, particularly Kupffer cells in the liver.
• Macrophage dysfunction can potentially affect liver function and drug metabolism.
• Cytochrome P-450 enzymes are crucial for drug metabolism and detoxification in the liver.

Purpose of the Study:

• To investigate the impact of Leishmania major infection on hepatic microsomal protein and cytochrome P-450 levels in mice.
• To determine if Leishmania-induced macrophage suppression affects liver microsomal enzymes.

Main Methods:

• Mice were infected with Leishmania major.
• Hepatic microsomal protein and cytochrome P-450 levels were measured at 6, 7, 9, and 12 weeks post-infection.
• Parasite load in Kupffer cells and phagocytic activity were assessed.

Main Results:

• Leishmania major infection led to significant parasite proliferation in Kupffer cells.
• A marked reduction in Kupffer cell phagocytosis was observed.
• Despite these changes, hepatic microsomal protein and cytochrome P-450 levels remained unchanged throughout the infection period.

Conclusions:

• Leishmania major infection does not inhibit hepatic microsomal protein or cytochrome P-450 levels in mice.
• Leishmania-induced macrophage suppression does not appear to affect these specific liver microsomal components.
• The liver's capacity for drug metabolism, as indicated by cytochrome P-450, is maintained during L. major infection.